Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Daewoong Pharma
KRX:069620
Daewoong Pharma
KRX:069620
Price:
109 600
KRW
3.1%
Market Cap:
₩1.3T
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Daewoong Pharma
KRX:069620
|
KR |
|
S
|
Sri Lotus Developers and Realty Ltd
NSE:LOTUSDEV
|
IN |
|
A
|
Anand Rayons Ltd
BSE:542721
|
IN |
|
Freehold Royalties Ltd
TSX:FRU
|
CA |
|
Iris Acquisition Corp
NASDAQ:LIMN
|
KY |
Wall St Price Targets
Price Forecast
Based on 12 analysts
Based on 12 analysts
+86% Upside
from
₩109 600
today
Daewoong Pharma (069620)’s 12-month stock price forecast through October 2027 has a consensus target of ₩204 000, implying 86% upside. The forecast is based on price targets from 12 Wall Street analysts.
Analyst Rating
No ratings yet
No ratings yet
Daewoong Pharma Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Daewoong Pharma's stock price target?
Price Target
204 000
KRW
204 000
KRW
According to Wall Street analysts, the average 1-year price target for Daewoong Pharma is 204 000 KRW with a low forecast of 181 800 KRW and a high forecast of 262 500 KRW.
What is the Revenue forecast for Daewoong Pharma?
Projected CAGR
6%
6%
Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 3 years is 6%.
What is the Gross Profit forecast for Daewoong Pharma?
Projected CAGR
7%
7%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 3 years is 7%.
What is the Operating Income forecast for Daewoong Pharma?
Projected CAGR
13%
13%
Over the last 13 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 3 years is 13%.
What is the Pre-Tax Income forecast for Daewoong Pharma?
Projected CAGR
10%
10%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 12%. The projected CAGR for the next 3 years is 10%.
What is the Net Income forecast for Daewoong Pharma?
Projected CAGR
4%
4%
Over the last 13 years, the compound annual growth rate for Net Income has been 14%. The projected CAGR for the next 3 years is 4%.